Clinical Trial Equipment and Ancillary Solutions Market Report 2025

This Clinical Trial Equipment and Ancillary Solutions market report provides a comprehensive analysis of the market’s characteristics, size, and growth, including segmentation, regional and country-level breakdowns, competitive landscape, market shares, trends, and strategies. It also tracks historical and forecasted market growth across various geographies.

The clinical trial equipment and ancillary solutions market size has grown strongly in recent years. It will grow from $2.54 billion in 2024 to $2.78 billion in 2025 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to rising prevalence of chronic diseases, increasing spending on research, growing pharmaceutical sector, growing medical sectors, growing patient-centric clinical trials.

The clinical trial equipment and ancillary solutions market size is expected to see strong growth in the next few years. It will grow to $3.92 billion in 2029 at a compound annual growth rate (CAGR) of 9%. The growth in the forecast period can be attributed to rising prevalence of chronic diseases, increasing spending on research, growing pharmaceutical sector, growing medical sectors, growing patient-centric clinical trials. Major trends in the forecast period include technological advancements, advancements in ancillary solutions, advanced developmental services, development of innovative equipment, developing innovative therapies.

The growing prevalence of chronic diseases is expected to drive the expansion of the clinical trial equipment and ancillary solutions market in the coming years. Chronic diseases are long-term conditions that typically require continuous medical care and can affect daily activities and quality of life. Factors such as exposure to air pollution, chemicals, toxins, lifestyle changes, and genetic predispositions contribute to the rise in chronic diseases. Clinical trial equipment and ancillary solutions play a critical role in improving outcomes for chronic disease patients by enabling early detection, personalized treatment, accurate assessment of treatment effectiveness, safety monitoring, patient engagement, optimized trial design, regulatory compliance, and fostering research collaboration. For example, the National Center for Biotechnology Information (NCBI), a US-based National Library of Medicine, projected in January 2023 that by 2050, the number of people aged 50 and above with at least one chronic illness will increase by 99.5%, growing from 71.5 million in 2020 to 142.66 million. As a result, the rising prevalence of chronic diseases is fueling the demand for clinical trial equipment and ancillary solutions.

Leading companies in this sector are focused on developing integration platforms to streamline workflow efficiency across diverse clinical trial systems and technologies. These platforms serve as centralized hubs, facilitating seamless connection and integration of various tools, technologies, and services utilized in clinical research. This integration enhances data and information exchange among different components of the clinical trial ecosystem, thereby improving efficiency and fostering collaboration among stakeholders. For instance in March 2022, Vibrent Health has announced the development of an Ancillary Studies Tool Suite as part of its Digital Health Research Platform, aiming to provide essential integration management tools for embedding existing digital apps, sensors, and data collection platforms into longitudinal cohort research.

In March 2024, Myonex, a US-based pharmaceutical company, acquired Creapharm Group for an undisclosed sum. Through this acquisition, Myonex seeks to strengthen its service offerings and capabilities for pharmaceutical and biotech companies by incorporating Creapharm’s expertise in clinical packaging, distribution, and bio services. This integration aims to deliver more agile and reliable solutions to clients at both the clinical and commercial stages, including those managing Advanced Therapies. Creapharm, a pharmaceutical technology company based in France, specializes in clinical trial equipment and ancillary solutions.

Major companies operating in the clinical trial equipment and ancillary solutions market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Agilent Technologies Inc., Iron Mountain Incorporated (IRM), PerkinElmer Inc., Illumina Inc., Sartorius AG, PAREXEL International Corp., Marken, Shimadzu Corporation, Waters Corporation, Bruker Corporation, Eppendorf AG, Tecan Group AG, Mettler Toledo International Inc., Hamilton Company, Repligen Corporation, Labconco Corporation, Ancillare LP, Binder GmbH, Germfree Laboratories Inc., Nuaire Inc., Sheldon Manufacturing Inc., Esco Micro Pte. Ltd.

North America was the largest region in the clinical trial equipment and ancillary solutions market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the clinical trial equipment and ancillary solutions market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the clinical trial equipment and ancillary solutions market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Clinical trial equipment and ancillary solutions encompass a wide array of products, services, and support systems essential for planning, executing, and managing clinical trials. These solutions play a crucial role in ensuring the safe, efficient, and compliant conduct of clinical studies across various therapeutic areas and phases of drug development. They support the successful completion of clinical trials, thereby contributing to the advancement of medical science and enhancing patient care.

The primary types of clinical trial equipment and ancillary solutions include diagnostic equipment, laboratory instruments, and ancillary solutions. Diagnostic equipment comprises specialized devices used in clinical trials for detecting, diagnosing, or monitoring health conditions or treatment effects. Various services provided encompass rental and leasing services, supply and logistics services, regulatory compliance services, and software services. These solutions are utilized by diverse end-users such as pharmaceutical and biotechnology companies, contract research organizations (CROs), medical device companies, and others.

The clinical trial equipment and ancillary solutions market research report is one of a series of new reports that provides clinical trial equipment and ancillary solutions market statistics, including clinical trial equipment and ancillary solutions industry global market size, regional shares, competitors with clinical trial equipment and ancillary solutions market share, detailed clinical trial equipment and ancillary solutions market segments, market trends, and opportunities, and any further data you may need to thrive in the clinical trial equipment and ancillary solutions industry. This clinical trial equipment and ancillary solutions market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The clinical trial equipment and ancillary solutions market consists of revenues earned by entities by providing services such as clinical trial supply services, laboratory services, data management and technology solutions, regulatory and compliance services, and training and support services. The market value includes the value of related goods sold by the service provider or included within the service offering. The clinical trial equipment and ancillary solutions market also includes sales of auditing tools, inventory management tools, and safety signal detection tools. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.